Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 102

Similar articles for PubMed (Select 12747770)

1.

Alternative roles for interferon-gamma in the immune response to DNA vaccines encoding related melanosomal antigens.

Wolchok JD, Srinivasan R, Perales MA, Houghton AN, Bowne WB, Blachere NE.

Cancer Immun. 2001 Aug 16;1:9.

2.

Tumor immunity and autoimmunity induced by immunization with homologous DNA.

Weber LW, Bowne WB, Wolchok JD, Srinivasan R, Qin J, Moroi Y, Clynes R, Song P, Lewis JJ, Houghton AN.

J Clin Invest. 1998 Sep 15;102(6):1258-64.

3.

Coupling and uncoupling of tumor immunity and autoimmunity.

Bowne WB, Srinivasan R, Wolchok JD, Hawkins WG, Blachere NE, Dyall R, Lewis JJ, Houghton AN.

J Exp Med. 1999 Dec 6;190(11):1717-22.

4.

Xenogeneic DNA immunization in melanoma models for minimal residual disease.

Hawkins WG, Gold JS, Blachere NE, Bowne WB, Hoos A, Lewis JJ, Houghton AN.

J Surg Res. 2002 Feb;102(2):137-43.

PMID:
11796010
5.

Effective induction of antitumor immunity by immunization with plasmid DNA encoding TRP-2 plus neutralization of TGF-beta.

Jia ZC, Zou LY, Ni B, Wan Y, Zhou W, Lv YB, Geng M, Wu YZ.

Cancer Immunol Immunother. 2005 May;54(5):446-52. Epub 2004 Nov 16.

PMID:
15750831
6.

Targeted interleukin 2 therapy enhances protective immunity induced by an autologous oral DNA vaccine against murine melanoma.

Niethammer AG, Xiang R, Ruehlmann JM, Lode HN, Dolman CS, Gillies SD, Reisfeld RA.

Cancer Res. 2001 Aug 15;61(16):6178-84.

8.

Genetic immunization of mice with human tyrosinase-related protein 2: implications for the immunotherapy of melanoma.

Steitz J, Brück J, Steinbrink K, Enk A, Knop J, Tüting T.

Int J Cancer. 2000 Apr 1;86(1):89-94.

PMID:
10728600
9.

Perforin and gamma interferon expression are required for CD4+ and CD8+ T-cell-dependent protective immunity against a human parasite, Trypanosoma cruzi, elicited by heterologous plasmid DNA prime-recombinant adenovirus 5 boost vaccination.

de Alencar BC, Persechini PM, Haolla FA, de Oliveira G, Silverio JC, Lannes-Vieira J, Machado AV, Gazzinelli RT, Bruna-Romero O, Rodrigues MM.

Infect Immun. 2009 Oct;77(10):4383-95. doi: 10.1128/IAI.01459-08. Epub 2009 Aug 3.

10.

Vaccination with an adenoviral vector encoding the tumor antigen directly linked to invariant chain induces potent CD4(+) T-cell-independent CD8(+) T-cell-mediated tumor control.

Sorensen MR, Holst PJ, Pircher H, Christensen JP, Thomsen AR.

Eur J Immunol. 2009 Oct;39(10):2725-36. doi: 10.1002/eji.200939543.

PMID:
19637230
11.

Naked DNA immunization as an approach to target the generic tumor antigen survivin induces humoral and cellular immune responses in mice.

Lladser A, Párraga M, Quevedo L, Carmen Molina M, Silva S, Ferreira A, Billetta R, G Quest AF.

Immunobiology. 2006;211(1-2):11-27. Epub 2005 Dec 27.

PMID:
16446167
12.
13.

Genetic vaccination with "self" tyrosinase-related protein 2 causes melanoma eradication but not vitiligo.

Bronte V, Apolloni E, Ronca R, Zamboni P, Overwijk WW, Surman DR, Restifo NP, Zanovello P.

Cancer Res. 2000 Jan 15;60(2):253-8.

14.

CD4+/CD25+ regulatory cells inhibit activation of tumor-primed CD4+ T cells with IFN-gamma-dependent antiangiogenic activity, as well as long-lasting tumor immunity elicited by peptide vaccination.

Casares N, Arribillaga L, Sarobe P, Dotor J, Lopez-Diaz de Cerio A, Melero I, Prieto J, Borrás-Cuesta F, Lasarte JJ.

J Immunol. 2003 Dec 1;171(11):5931-9.

15.

Tumor endothelial marker 8 enhances tumor immunity in conjunction with immunization against differentiation Ag.

Felicetti P, Mennecozzi M, Barucca A, Montgomery S, Orlandi F, Manova K, Houghton AN, Gregor PD, Concetti A, Venanzi FM.

Cytotherapy. 2007;9(1):23-34. doi: 10.1080/14653240601048369.

PMID:
18236207
16.
17.

Induction of melanoma-associated antigen systemic immunity upon intratumoral delivery of interferon-gamma retroviral vector in melanoma patients.

Fujii S, Huang S, Fong TC, Ando D, Burrows F, Jolly DJ, Nemunaitis J, Hoon DS.

Cancer Gene Ther. 2000 Sep;7(9):1220-30.

18.

The role of gamma interferon in DNA vaccine-induced tumor immunity targeting simian virus 40 large tumor antigen.

Aldrich JF, Shearer MH, Lowe DB, Winn RE, Jumper CA, Kennedy RC, Bright RK.

Cancer Immunol Immunother. 2013 Feb;62(2):371-82. doi: 10.1007/s00262-012-1338-x. Epub 2012 Aug 25.

PMID:
22926061
19.

A melanosomal membrane protein is a cell surface target for melanoma therapy.

Takechi Y, Hara I, Naftzger C, Xu Y, Houghton AN.

Clin Cancer Res. 1996 Nov;2(11):1837-42.

20.

Immunization with DNA coding for gp100 results in CD4 T-cell independent antitumor immunity.

Hawkins WG, Gold JS, Dyall R, Wolchok JD, Hoos A, Bowne WB, Srinivasan R, Houghton AN, Lewis JJ.

Surgery. 2000 Aug;128(2):273-80.

PMID:
10923004
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk